Taken together, SLC7A11 acted as a ceRNA for STX17, UVRAG, and RAB33B in 20, 12, and 12 different tumor types, respectively (Table 1 and Figure 12), and acted as a ceRNA for the three genes in 379 OC tissues (Table 1 and Figure 9) and in 90 drug-resistant tissues (Figure 11). This evidence concerns the gene SLC7A11 and neoplasm.